首页|EBV相关性胃癌的流行病学、分子特征及其免疫治疗策略的临床应用

EBV相关性胃癌的流行病学、分子特征及其免疫治疗策略的临床应用

扫码查看
EBV相关性胃癌(EBV-associated gastric cancer,EBVaGC)是一种与 EB 病毒(Epstein-Barr virus,EBV)相关的胃癌类型,虽然其发病率较低,但具有独特的临床特点.EBVaGC患者多为年轻男性,且初诊时大多为局部晚期,尽管如此,其预后较好.该类型胃癌的肿瘤微环境中常见显著的淋巴细胞浸润,呈现出更"热"的免疫微环境.研究表明,晚期EBVaGC患者对免疫检查点抑制剂的治疗反应优于普通胃癌患者.本文综述了EBVaGC的疾病特征、临床诊治进展及免疫治疗的潜力,旨在为深入探讨该病的免疫微环境、免疫治疗策略及耐药机制提供指导,为临床治疗与前瞻性试验设计提供理论依据,以期推动该领域的进一步研究.
Epidemiology,molecular characteristics,and clinical application of immunotherapy strategies for EBV-associated gastric cancer
EBV-associated gastric cancer(EBVaGC)is a type of gastric cancer related to the infection of Epstein-Barr virus(EBV),with a low incidence rate.EBVaGC tends to occur in younger patients,male predominance,and is often diagnosed as locally advanced with a good prognosis.The tumor microenvironment of EBVaGC is characterized by significant lymphocyte infiltration,contributing to a more active immune landscape.Patients with advanced EBVaGC have a higher response rate to immune checkpoint inhibitors compared to patients with ordinary gastric cancer.This article reviews the disease characteristics and the treatment progress of EBVaGC.

gastric cancerEpstein-Barr virusepidemiological characteristicsclinical featuresprognosis

邱妙珍、徐瑞华

展开 >

中山大学肿瘤防治中心内科,华南恶性肿瘤防治全国重点实验室,肿瘤医学协同创新中心,中国医学科学院消化系统肿瘤精准诊治创新单元,广州 510060

胃癌 EB病毒 流行病学特征 临床特征 预后

2024

中国科学(生命科学)
中国科学院

中国科学(生命科学)

CSTPCD北大核心
影响因子:0.725
ISSN:1674-7232
年,卷(期):2024.54(12)